EyeBio
Entity

  • EyeBio

    Created in 2021


  • Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    6,156

  • Activities

    biotech deeptech

  • Entity types

    Startup

  • Location

    London, UK

    London

    United Kingdom

  • Employees

    Scale: 11-50

    Estimated: 109

  • Engaged catalyst

    2
    0 0

  • Added in Motherbase

    5 months, 2 weeks ago
Description
  • Value proposition

    Developing a new generation of therapies to protect, restore, and improve vision

    EyeBio is a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore, and improve vision in patients with sight-threatening eye diseases.

    ophthalmology, biopharmaceuticals, and biotechnology

Catalyst interactions
Catalyst Type Tweets Articles
MSD
MSD
Pharmaceutical, Pharmaceutical Manufacturing (Auto)
MSD
Pharmaceutical, Pharmaceutical Manufacturing (Auto) 		Other

15 Jul 2024


Sofinnova Partners
Sofinnova Partners
Financial Services (Auto)
Sofinnova Partners
Financial Services (Auto) 		Other

12 Jul 2023


Social network dynamics
Similar entities
BETA
Last news
Show all articles